Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BD Biosciences to Expand Manufacturing in Durham, North Carolina

Published: Monday, May 14, 2007
Last Updated: Monday, May 14, 2007
Bookmark and Share
The expansion of Treyburn facility will consolidate and increase U.S. manufacturing for BD Biosciences’ Discovery Labware product line.

BD Biosciences, a segment of BD (Becton, Dickinson and Company), has announced plans to expand its Treyburn facility in Durham, North Carolina to consolidate and increase U.S. manufacturing capacity for its Discovery Labware products, including BD Falcon™ products.

The $25 million capital investment project is expected to create 28 new positions in 2007 and a total of 100 by the end of 2008, building on a presence of approximately 285 employees today.

With expertise in fluid handling, tissue culture, and cell screening, BD Biosciences - Discovery Labware provides products and services with applications for drug discovery, high throughput screening, angiogenesis and tumor invasion.

The new capacity is intended to meet growing demand for BD Falcon™ tubes, pipettes, plates, cell inserts, and other products used in life science research settings. Approximately 50,000 square feet of manufacturing space will be added, directly contiguous to existing production lines.

“Treyburn offers an ideal platform as BD looks to increase capacity to meet demand for our Discovery Labware products,” said Todd Shackett, Plant Manager of the Treyburn facility. “We are able to build upon our own successful manufacturing operations, as well as the pool of high-tech expertise in this region. We couldn’t be more pleased to be growing in Durham. Today’s moves will provide the cornerstone for future development.”

Bill Kozy, Executive Vice President, added: “This expansion will allow BD to meet growing demand for class-leading products that are critical tools for life science researchers everywhere, while also enabling us to optimize our global production and supply chains for related products.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
Crystal Clear Images Uncover Secrets of Hormone Receptors
NIH researchers gain better understanding of how neuropeptide hormones trigger chemical reactions in cells.
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!